60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment

Go back to 60 Degrees Pharmaceuticals partners with Tulane to study lyme treatment
(NASDAQ: SXTP) Delayed: 1.51 -0.01 (0.66%)
Previous Close $1.52    52 Week High
Open $1.55    52 Week Low
Day High $1.55    P/E N/A 
Day Low $1.47    EPS
Volume 10,088       

(NASDAQ: SXTPW) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 2,102